Colgate-Palmolive (NYSE:CL) Position Boosted by MONECO Advisors LLC

MONECO Advisors LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 18.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,615 shares of the company’s stock after purchasing an additional 885 shares during the period. MONECO Advisors LLC’s holdings in Colgate-Palmolive were worth $448,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Colgate-Palmolive by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock valued at $6,368,378,000 after buying an additional 416,853 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Colgate-Palmolive by 16.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 32,133,218 shares of the company’s stock worth $2,561,340,000 after purchasing an additional 4,625,472 shares in the last quarter. Morgan Stanley lifted its position in shares of Colgate-Palmolive by 3.2% in the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock worth $1,195,785,000 after purchasing an additional 514,559 shares in the last quarter. Northern Trust Corp lifted its position in shares of Colgate-Palmolive by 3.3% in the third quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock worth $672,198,000 after purchasing an additional 305,862 shares in the last quarter. Finally, Norges Bank acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $731,843,000. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Barclays increased their price target on Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, April 30th. Wells Fargo & Company increased their price target on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. Bank of America increased their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, April 29th. Evercore ISI raised their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Finally, Stifel Nicolaus raised their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Three investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $92.94.

Colgate-Palmolive Stock Performance

NYSE CL traded up $1.38 on Monday, reaching $96.00. The stock had a trading volume of 1,565,103 shares, compared to its average volume of 4,427,172. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a fifty day moving average of $91.70 and a two-hundred day moving average of $86.27. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $96.08. The company has a market cap of $78.76 billion, a P/E ratio of 29.94, a price-to-earnings-growth ratio of 3.48 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the firm posted $0.73 EPS. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.08%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Insider Buying and Selling

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 12,226 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.